Latest news with #Lyndsay
The Market Online
03-06-2025
- Business
- The Market Online
Inside ReGen III's Base Oil Breakthrough
ReGen III Corp. (TSXV:GIII), a Canadian clean tech company pioneering the upcycling of used motor oil into high value Group III base oils through its patented ReGen™ technology, is sitting with us today and, with its flagship facility in Texas City, Texas, currently in the engineering phase, ReGen III aims to process 5,600 barrels per day of used motor oil, offering a sustainable alternative to traditional refining methods. Lyndsay Malchuk from Stockhouse Publishing recently sat with Tony Weatherill, CEO of ReGen III to discuss the company's progress and future plans. Lyndsay: I would like to kick off with the pain point that you are seeing now. ReGen III has a unique clean technology. So tell us about the critical problems your process addresses here. Tony: Yes, well the fundamental business of ReGen III is recycling used motor oil to produce a higher quality product, predominantly a Group III base oil. But the industry faces some critical problems. Over half of all used motor oil in the United States finds its way into the environment or into a burner, which is a major environmental problem. Of the 25% of used oil that is re-refined, only 1-2% of this is a Group III quality. Group III, just as a reminder, is the basis of modern synthetic lubricants. And indeed Group III is the fastest growing base oil category, but almost no re-refined supply globally. There is lack of Group III production in the United States, so approximately 85% of North America's requirements are actually imported from Korea and indeed the Middle East, which means that the United States is heavily dependent on foreign sources. Lyndsay: So in your experience then Tony, why do these problems exist? Tony: Well refining technology is dated. The traditional process yields lower-value, lower-quality base oils, which are abundant in supply as they produce a low value product. Re-refining economics for these products and projects are generally poor. High capital costs act as a barrier to entry. The process inherently generates low margins. As a consequence, very few new re-refineries are being built. Indeed, in the last 10 years, only one new base oil re-refinery has been built. And it's not a Group III facility, it's a Group II plant. And low value feedstock. Typically quick lube facilities pay to have the waste used motor oil taken away. And indeed some of these used oil generators opt to discard it into the environment, regrettably or indeed burn it at their shop. So to summarize, it really comes back to the technology being dated and limited to a lower value product. Lyndsay: How does the ReGen™ technology differ then, and why ultimately would you think it's the best re-refining choice on the market right now? Tony: That's a great question. Our process is inherently different. So we take the standard two stage re-refining process of distillation and hydro processing and insert a middle stage to produce a high-value Group III product. We use high efficiency solvent extraction technology in our molecular separation unit, or MSU as we would call it, to cost-effectively isolate the Group III molecules from the used motor oil. It's a proven technology in oil and gas, but we do tailor it for used motor oil refining. As a consequence, we produce over 50% yield of Group III, and that comes with a 50% price premium. Historically throughout the entire commodity cycle, the economics are still very attractive. So we believe we have a significant competitive advantage. Additionally, we also have a second product stream, which we upgrade through hydrotreating. It's small volume which saves on energy, hydrogen and catalyst but we produce a very valuable Group II+ product. So overall, our process reduces emissions from production by 36% versus virgin base oils while protecting the environment from harmful toxins. So if I could summarize, our project generates exceptional re-refining economics, boosts vital domestic Group III supplies, reduces the amount of used motor oil burned or dumped today and improves carbon circularity and increases the value of used motor oil. So just to repeat, 740 million gallons a year are being absorbed into the environment. A project like Texas City could divert about 10% of that. Lyndsay: That's phenomenal stats right there. Now, Tony, let's flip to your recently completed pilot studies. Can you tell us a little bit more about the results and how they validate the technology? Tony: Well perhaps a quick recap. So our technology has been validated numerous times in the past, various technical feasibility and pilot studies over the last decade. But we've also done a latest round of testing and we keep testing because we want to be sure we do take a conservative approach at ReGen III. But those results, critically, have been verified by additive companies, lubricant blenders, and major oil companies. And the results have been exceptionally good, surpassing our expectations. So Group III yields, they're exceeding our base design of 53%. Viscosity index, we need to get to 120 to be considered a Group III, and our results are well above that, which is excellent. Color is fantastic, and I just happen to have a glass of water here. It would actually look like that. And NOAC volatility was also above expectations. NOAC measures the evaporation loss at high temperatures. The importance of that is it's important to lubricant blenders and consumers because it extends engine oil life, lengthens time between oil changes, and increases your engines longevity. In summary, we have a solution to several critical problems in the base oil and lubricants market. We have an innovative patented technology that addresses an unmet market need. Our pilot results continue to exceed expectations. We are very much looking forward to commercializing this technology and we have some very exciting strategic developments that are being advanced. ReGen III Corp's website is and you can find them on the Venture Exchange under the ticker symbol GIII and on the OTCQB under the ticker symbol ISRJF. Join the discussion: Find out what everybody's saying about this stock on the ReGen III investor discussion forum, and check out the rest of Stockhouse's stock forums and message boards. The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here
The Market Online
22-05-2025
- Business
- The Market Online
Turning Plastic Waste into a Commercial-Grade Renewable Green Condensate
PlasCred Circular Innovations is turning plastic garbage into a commercial-grade product — and doing it in a way that challenges how we think about recycling. Lyndsay Malchuk recently caught up with President and CEO Troy Lupul, to spotlight the who, what and how it's all possible. The following is a transcription of the above video, and The Market Online has edited it for clarity . Lyndsay: The first question is, you know, your tech turns mixed plastic waste, really the things that nobody wants, into something petrochemical giants are eyeing. Now, is this just better PR for plastic or are you actually changing the game? Troy: No, we are a real game changer. What we primarily focused on in the beginning for the evolution of plastic credits, which is PlasCred, what we wanted to do is focus on plastic that will never be recycled. Stuff that'll definitely land in the landfill or incinerated or god forbid, the ocean. So, what we've been able to do is focus in on plastics that were just basically difficult, like your Tesla dashboard, your pen, your glasses, your medical waste. We really focused in on things that were not being recycled. So, it is a game changer. Lyndsay: Your process converts up to 80% of landfill bound plastics into renewable green condensate. So why hasn't anyone else done this and what's stopping the oil majors from just copying you? Troy: Well, that's a simple question. Most majors like Shell and Exxon and some of the bigger producers that make plastic as well as do crack ethane, they're not aggregators of plastic. They're not garbage people. They're not going to go out and do dumpster diving and chase. It's not in their mandate or their core competency. So realistically, they build refining capabilities. They're not into, even though they make the virgin feedstock, plastic, they're not aggregators of plastic. And that's where we've created a huge gap between the oil and gas world and the plastic world. Lyndsay: Why don't we talk about your pilot. The, the Primus pilot has been running for two years now. So what have you learned and really what steps are the next steps to scaling the operation? Troy: That's one of the expertise because we are, you know, our DNA is hydrocarbons and we're in Calgary and we've got a lot of phenomenal talent here. What we've been able to achieve is what I'm going to say, a very large pilot plant that's very scalable. And what we wanted to do is de-risk it for the investment community, is to allow ourselves to build a big enough pilot plant, which we call Primus, and then be able to scale it to the 500 barrels a day, which will be our next phase. Lyndsay: Let's talk CN Railroads, they don't usually bet on early stage cleantech, so what's the real value proposition you sold them on and really how critical is this partnership to scaling nationally? Troy: Well, when we look at plastics as a whole in North America we needed to have a backbone. And we took a page out of Jeff Bezos, logistics, logistics, logistics. And one of the unique features about CN, it's really driven by them, is the fact that, as you know, in North America, most of our goods come from the west coast, go to Chicago, go to Toronto, and there's a lot of empty sea container boxes sitting there as liabilities sitting in these yards doing nothing. So what we wanted to do is take advantage of that backhaul, and this is a crown jewel in our story. We have a competitive advantage to get huge volumes of feedstock in these empty sea containers and backhaul them. Instead of hauling an empty sea container back to Vancouver or Prince Rupert or to Newport Beach, we can actually fill it up with waste plastic, bring it to the best place in the world, which is Fort Saskatchewan to face change that feedstock into a renewable molecule. And that's a huge back haul story for CN. So CN has a been a phenomenal champion of us and we couldn't build this big of a plant without them. So, we're super excited for them as a partner. Lyndsay: You've recently actually also signed a five year agreement with a global commodities company. Now, Troy, that's big, but what happens if they like your product and they don't like your price? Are you building a business model or just hoping for a buyout? Troy: No, we are here for the long term. We have built a molecule, a renewable molecule that is repurposed back. And that's one of the things that we're doing differently, is that we are creating a renewable molecule. And by creating a renewable molecule, it can go into all these petrochemical companies around North America. We're building it and we're not making transportation fuel. We're not doing anything silly like that. All we're doing is taking the worst grade of plastic efficiently, bringing it back and taking advantage of the billions of dollars worth of infrastructure in North America that's already built and repurposing that molecule to basically go back into making other building blocks of plastic. So think of it as advanced chemical recycling. Advanced recycling that is done at a large scale, takes advantage of a huge problem. The future looks incredibly bright for us. We're super excited about building our first phase, which is Neos 500 barrel a day system. Lyndsay: This is such an innovative thing that you've done, and I'm really actually truly surprised that no one's thought about this before. The simple things like the highlighter we use, like you said, the pen, the parts of the EV cars or whatever that nobody's thinking about what happens after. Troy: The carpet you're walking on right now, your television set, these are the things that we as a human species consume every day for plastics. And I know governments are trying, but we are the real outlet. Like we needed to create this advanced recycling capability because we could throw all the legislation at it you want, and straws well, that's pretty simplified. I mean, that really doesn't move the needle. The real plastics are the things that don't get caught. We're talking like medical waste. We're talking agricultural waste. We're talking things that are ending up in the ocean. And if you look at it, we are a type of species that needs plastic. Our planes are made from it. Our cars, our computers, our lifestyle. So we need to come in with a real advanced and basically we're all we're doing is we're taking and pushing away the virgin feedstock. So instead of drilling, fracking and going after that virgin feedstock that the petrochemical companies need, we're basically offsetting that virgin feed stock, which gives a reduction in CO2 by about 92%. So that's a real impact that I can actually show you physically and also show you what we're redoing for a renewable molecule. Lyndsay: I know that we just have a little bit of time left, but we spoke a little bit about this last time off camera. I want to know what got you into this. Troy: My background is water treatment, and when I got into doing what is called removing microplastics from water, what I couldn't understand was the reject stream or basically once you remove the plastic, it went back into the water again. So why would you clean the water and send it back? And one of the things, using my own funds, I went around the world and I couldn't figure out why this was not working. And what you saw in life is that people think that you can grind plastic and reuse it. It doesn't work that way when you have cross contamination because there's so many species of plastic. So when you're sitting on a Boeing plane or an Airbus, the back of that seat plastic is so much different than your pen. Your computer screen is much different than what you have as a kid's toy. So, when you co-mingle those species of plastic, they're unrecyclable, they're just too much to sort out and grind. Whereas what we've done is we've basically have created a funnel where we can take all species of plastics no matter what we use on terra firma, and we can put that back to original Mother Earth molecule. And that happened because we've got the skillset here. We've got this incredible talent pool in our own country and in Alberta where we build these complex refineries. And a lot of it leads to, what I would say is much more complicated problems like taking sulfur out of gas, Sag-D thermal. So we took all those talents and we applied it to this problem, and that's why we've been so successful compared to anybody else in the world. A lot of petrochemical companies want a renewable molecule. They have an ethical choice. If I'm going to make billions of tons of plastic and sell it to, Ford, GM, all the automotive, medical, I need a recycling story. But I can't do that with mechanical guys. They're not big enough and the logistics isn't there. Here we've got a backbone with CN, and now we can create a renewable molecule that takes advantage of North America's infrastructure, which is billions of dollars worth of refining capacity that can offset virgin feed stock and repurpose it back into plastic again. So, think of me as an above ground oil company. I'm drilling into an above ground oil field. Lyndsay: So perfectly put. Now, you've listened, you've experienced things firsthand, and then you built that bridge, which is such a huge step for you. And I'm so happy that you were able to come on and just break this all down for us, literally. Troy: Thank you. And the goal here is we're we've got a good team. We've got good pedigree in this. We've all been into the bigger projects, but I'm super excited about this company because it does make an impact. You can actually visually see it, you can actually see different species of plastic coming out of the ocean. We can two phase that back to a renewable molecule and that's what's really gratifying. Whereas, you know, other things are kind of greenwashing, whereas here it's got a really big impact. You can actually physically see it. You can PlasCred Circular Innovations Inc. on the CSE under the ticker symbol PLAS and their website is Join the discussion: Find out what everybody's saying about this stock on the PlasCred Circular Innovations investor discussion forum, and check out the rest of Stockhouse's stock forums and message boards. The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here
The Market Online
21-05-2025
- Business
- The Market Online
Developing new therapies for traumatic central nervous system injuries
NurExone Biologic Inc. , an innovative biotech company pioneering exosome based therapies designed to help patients recover from traumatic central nerve system injuries. There's a lot happening at NurExone from the formation of a US subsidiary and a new CEO to lead that subsidiary to their plans for uplisting to a major US exchange and recent funding activity. Lyndsay Malchuk recently caught up with CEO, Shaltiel to an inside scoop on some exciting preclinical results and an upcoming scientific report that can mark a major step in the research development. The following is a transcription of the above video, and The Market Online has edited it for clarity . Lyndsay: I think the best place to actually start is with that US subsidiary. So tell us maybe a little bit about Exo-Top and can you tell us about the new Exo-Top CEO? Lior: Yes. So let's start with the context. We bought just recently in the end of last year, huge assets, which is the master cell bank in the US, a former US company. And these assets will stay in the US and this is the reason that we open the subsidiary there. The aim of the subsidiary is first of all to hold the master cell bank, develop it to a working cell bank and produce naive exosomes, which is the first step of our therapy for NurExone's supply, NurExone Ltd for further research and development for clinical phase. And because we are sitting on large assets, also offer exosomes in the highest standards as a B2B business for cosmetic, aesthetic and other vendors that would like to purchase it. Regarding the CEO, I'm very glad to have Jacob Licht on our Board. He came with more than 25 years of experience in a large pharmaceutical, including a lot of experience in operations and M&A. I think that bring NurExone to a new level. Speaking American and not just entrepreneurship Israelis. Lyndsay: Let's peel back just a little bit more here if we can. Now you've engaged with a number of North American investment banks in order to achieve that US exchange listing. So my question is, what can you share about that process, where it stands and what it means for NurExone's next phase of growth? Lior: Sure. So, we completed in April a $2.3 million Canadian dollar raise. We are well funded with the back wind of a very successful JP Morgan event in San Francisco. We got a lot of the attention from US and Canadian investment banks. And our plan is now to up list NurExone from Canada to a major stock exchange in the US in order to be in the right market. Because as you know, the majority of large pharmaceuticals that got into a clinic need to be on a major stock exchange with the support of the market and the liquidity. And we will get the support from these investment banks to raise in two steps pre IPO raise and after that a full IPO to a major stock exchange in the US. Lyndsay: How do you plan to use the funds to work and are you looking at any additional support from the government for grants in Israel? Lior: Yes, we are looking all the time non-governmental funds. We have interest from the Israeli defense ministry in order to apply NurExone products in the battlefield. I believe that it'll also be relevant for the US DOD, (Department of Defense). So non-governmental is of course one of the sources to support NurExone. But on top of that, as I said, we would like to use the raise now and the raise that we completed in April in order to proceed into a clinical stage company and provide all the necessary IND enabling study in order to submit it to the FDA. Lyndsay: I'm going to flip over here to go over some preclinical information that's exciting as well. So, the latest preclinical results around the ExoPTEN look really promising when it comes to improving motor function. So for you, what stood out in the findings? I mean, how does this move the needle for your research? Lior: That's a very good point. We changed models at NurExone, moving from a very, very severe and not physiological model, which is full transection the spinal cord, which we could see a motor sensoric and bladder functional recovery. But now we move to a more physiological in order to get more physiological data in a compression model, meaning that you're pressing the nerves and not cutting it. That's more of a fit to what happens to a human when you have an injury. And we see even stronger recovery. Okay. If you take a scale, the scale of motor recovery is even higher when you use the therapy. So this gives us a lot of hope that we are in the right direction. On top of that, we have also the results that we are getting more and more rats into the optic nerve damage showing the same strong recovery after just 18 days in an ERG. I think we are on the right track. We need to make sure that we have the whole package that the necessary for the FDA in order to translate our company to a clinical stage company. Lyndsay: Let's lean into that research further. I know that there's a scientific report that's coming out soon as well. So how big of a moment is that for you and what kind of response are you hoping for from regulators or investors or even potential partners? Lior: The correspondence with the FDA is critical. So one of the things that we want to keep is the dialogue. The last one that we had is in the end of 2023 when we completed the pre-IND. Since then we had a lot of progress. Our research became even more advanced, the production that we do in the 3D bioreactors is getting more advanced. So we have more questions today to the FDA and when sharing that we are getting ourself more focus, what is the right track? So, keeping the dialogue is critical and we are working with the regulator to help us bring the therapy further into a clinical stage. NurExone Biologic's website is and you can find them on the Venture Exchange under the ticker symbol NRX. Join the discussion: Find out what everybody's saying about this stock on the NurExone Biologic investor discussion forum, and check out the rest of Stockhouse's stock forums and message boards. The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here
Daily Record
12-05-2025
- General
- Daily Record
Wishaw primary school embarks on its first international partnership connecting with pupils in war-affected Ukraine
Wishaw Academy Primary School is among 100 schools in the UK and Ukraine officially paired through the British Council's UK-Ukraine School Partnership programme, funded by the UK Government, which uses a shared love of reading to foster cultural understanding and support emotional wellbeing. A Wishaw primary school has embarked on its first-ever international partnership connecting with pupils in war-affected Ukraine, as part of a landmark programme using literature to build bridges across borders. Wishaw Academy Primary School is among 100 schools in the UK and Ukraine officially paired through the British Council's UK-Ukraine School Partnership programme, funded by the UK Government, which uses a shared love of reading to foster cultural understanding and support emotional wellbeing. Lyndsay Ellis, who teaches P6 at Wishaw Academy, applied for the programme initially and describes the partnership as a great opportunity that aligns with the school's existing 'Rights Respecting' work. She said: 'It allows our children to pass on the joy they've found in books to someone else, while also giving them the chance to meet other people. Particularly with Ukraine, it ties in beautifully, as we're discussing empathy, respect, resilience, and all those important values.' The school, which has already been accredited through Scottish Reading, is now collaborating with Ternopil Lyceum 21, an arts school in Ternopil, in Western Ukraine. The pupils are meeting together online every week, reading together, and practicing English. Wishaw Academy Primary was the first school in Scotland selected to take part. In February, staff attended a residential training and networking event in Poland alongside 15 UK and 15 Ukrainian schools. As the only Scottish representative in her cohort, Lyndsay travelled to Poland for the training and to meet her Ukrainian counterpart Anzhelika Lishchenko. She said: 'To actually sit face-to-face with someone who's living in a war zone was really an eye-opener. We have no grasp of that working in schools in Scotland - what it means to be heading for a bunker every day and the trauma that must put their kids through.' As part of the project, the classes have exchanged letters and videos to introduce themselves. 'When I came back from Poland, I gave them the letters received from the class in Ukraine - they were beautifully written and the children had drawn little pictures,' Lyndsay said. 'My pupils had recorded introduction videos and the Ukrainian children responded with their own. While we had consciously avoided mentioning the war, several of the Ukrainian children mentioned it in their letters, which my class found really interesting.' Over the past two months, the two classes have met regularly online, with teachers allowing students' interests to shape their interactions. She said: 'We really want the pupils to lead the discussions. When we came off the first video call, the children all said, 'we need to prepare questions for next time'. They want to maximise the time, they just loved it.' The Wishaw pupils were particularly struck by the similarities they discovered with their Ukrainian peers and Lyndsay believes the benefits from the partnership will extend beyond the classroom. She said: 'The children were really blown away at finding somebody in the class who likes to cycle just like them, or boys who are really into football. 'For the class, this connection gives them an idea that there's a wider world, but that despite the distance and what these kids are going through, they're still doing the same things, have the same hobbies and wishes for the future.' The partnership has also created a special opportunity for two Ukrainian pupils who joined Wishaw Primary's infant department three years ago. Originally from Odessa and now in primary two, they were thrilled to take part in the online calls. Lyndsay said: 'They were very excited. One of them was quite concerned when she heard I was going to meet Ukrainian teachers - she didn't think going to Ukraine was a good idea at all!' Looking ahead, Lyndsay hopes to develop collaborative reading projects using dual-language books provided by the British Council, which feature the same stories in both Ukrainian and English. She said: 'The plan is to create something tangible together, we'll arrange for the Ukrainian pupils to read in their language and our pupils in English - letting them hear native speakers while creating something meaningful together.' *Don't miss the latest headlines from around Lanarkshire. Sign up to our newsletters here.
The Market Online
08-05-2025
- Business
- The Market Online
Visionstate set to prosper from Ontario Bill 190
Visionstate Corp. ( is a company focused on smart technology solutions that are transforming the way businesses manage facilities, operations, and sustainability efforts. Now their flagship product, Wanda is already making an impact in the facility management space and the company continues to expand its reach into new markets and technologies John Putters, CEO and Shannon Moore, President join Lyndsay Malchuk for the latest developments. The following is a transcription of the above video, and The Market Online has edited it for clarity . Lyndsay: So Shannon, maybe we can actually start with you. I mean, you made a recent announcement about your sales pipeline and deployment, But first, let's talk about the latest technology update, especially around that Ontario Bill 190. Can you explain that Bill just a little bit and what challenges it presents? Shannon: Absolutely. So the legislative requirement, Ontario now with Bill 190 is to mandate employers to provide access to real time blogs and service records. This is really about emphasizing proper cleaning standards. At the core of it, we're talking about compliance, we're talking about a solid infrastructure, we're talking about clean staff rooms in an environment where maybe those logs were manual or maybe even inconsistent. So at the heart of it, you're talking about accurate, accessible and timestamped. And really the way to do that is you pull those requirements into electronics, to data, so that they're accessible for everybody. Lyndsay: Well, that's a smart move right out of the gate for sure. So how does Visionstate's technology help address those challenges then more so than just going into technology? Shannon:, When we first read the bill, we were all like, this is what Wanda does and this is what we are delivering to all of our customers. But Wanda does a whole lot more than that. We also have alert systems, we have work order systems, we have communication systems, so it's a really robust software. But the truth of the matter is not everybody needs a fully robust software, and we're aware of that, especially with entry level into data collection. So we really studied the bill and made sure that we answered exactly those requirements, hold those out of our Wanda system and created a 'Wanda Light'. The advantage to that is giving our customers a couple of really great things. First, that gives them an easy answer that's low cost, simple, not overwhelming, they can install it themselves, and answer the bill, but then they can also see if they like collecting this data and maybe do they want to expand on it and add some of our other functionality. Lyndsay: So let's move then over to the sales pipeline. Shannon, what can you tell investors about where things stand right now? Shannon: This is a really important piece of the puzzle. Ontario obviously with this legislation is giving us a lineup and it's starting strong in post-secondary. It's starting very strong in municipalities and it will expand from there. It's a requirement through all of Ontario and our sales partner bundle is bringing it to every single one of their customers as a requirement. I would hope that as that expands, we start looking into the whole country, not necessarily because it's a legislative requirement, but it's the right thing to do and to ensure that these standards are met in all of their stack washrooms. Lyndsay: So John, let's pull you into the conversation here. In terms of deployment, what progress has been made so far and what kind of feedback are you getting from clients? John:, I think we're very much at the beginning of the digitalization process of the facility management industry. Everybody's familiar with a piece of paper that's , always in the restroom and really it's reflective of where that was at. It was really a sign off. Well, we're in an age of AI and analytics so you can't really achieve your goals that way, so we're finding now that not only is it being legislated but it's a requirement in order to stay competitive in the industry. What we're seeing is a lot of our customers are leveraging this technology to get more business, in fact, because they're saying, look, we can provide historical information and analytics. and we're three quarters of the way through an extremely interesting AI project with Alberta Machine Intelligence Institute, which is one of the leading institutes across the world, which will have a huge impact on facility management. So we're finding the adoption rate going up significantly. You know, it obviously helps when governments decide to legislate because that sets the direction for the future. So we're very excited about that. Lyndsay: So John, something investors might not be as familiar with is you have a potential 40% equity stake in s soul spaces, and they've been getting a lot of attention for their high tech greenhouses. So what can you tell us about the company and what they're working on? John: You're right, they have developed an expertise around high-tech greenhouses and that's done them very well, for example with First Nations communities. It's really all about food security, I think it was bad enough with climate change issues and supply chain disruptions, but now you have tariffs on top of it all, so there's more and more movement toward localization. But the fact of the matter is that old technology doesn't really work in extreme temperatures, so this is where the technology comes in. But I should also mention that's a stepping stone for them into really disrupting the construction industry, which I think is required in order to meet goals around sustainability and affordability. It just doesn't exist today. So, similar to the way Tesla took the combustion engine and introduced technology to produce the electric vehicle, they're taking the same approach to construction and we're starting to see the results of that because it's inevitable. So, we're really excited about their prospects and they just keep growing leaps and bounds. You can find Visionstate on the venture exchange under the ticker symbol VIS, and their website is Join the discussion: Find out what everybody's saying about this stock on the Visionstate Corp investor discussion forum, and check out the rest of Stockhouse's stock forums and message boards. The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here
